Navigation Links
Diabetes researchers pioneer islet cell xenotransplantation in primate studies

A team of researchers from the University of Alberta, the Yerkes National Primate Research Center of Emory University and the Emory Transplant Center has successfully transplanted insulin-producing neonatal porcine islet cells into monkeys, a procedure the researchers say represents a promising intermediate solution to the critical supply problem in clinical islet cell transplantation.

"Our work at the U of A and Emory, along with recent work at the University of Minnesota, is very exciting and shows that xenotransplantation in humans may soon be possible, thus solving the islet supply problem," says one of the study authors Ray Rajotte, a professor of Surgery at the University of Alberta.

The paper appeared in an advanced on-line publication of Nature Medicine, February 26, entitled "Long-term survival of neonatal porcine islets in non-human primates by targeting co-stimulation pathways." The work follows on the heels of similar work published last week by University of Minnesota researchers; those researchers used islets isolated from adult pig pancreases.

Neonatal islets were produced in Edmonton using a procedure Drs. Greg Korbutt and Rajotte developed in 1995. The pig islets were sent to the Yerkes Research Center for transplantation into diabetic rhesus macaques using an anti-rejection protocol developed by Drs. Christian Larsen and Kenneth Cardona of the Yerkes Research Center and the Emory Transplant Center. The isolation method developed by the U of A researchers is simple and reproducible with the neonatal pig islets having some growth potential post-transplant, considered a major advantage over adult pig islets.

The diabetic animals were treated with a CD28/CD154 co-stimulation blockade-based immunosuppressive regimen, and achieved sustained insulin independence (median survival >140 days with one animal now at 300 days) without evidence of porcine endogenous retrovirus (PERV) dissemination. "This represents a major step for
'"/>

Source:University of Alberta


Page: 1 2

Related biology news :

1. FDA Approves New Drug to Treat Type I and Type II Diabetes
2. First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes
3. Single-donor Islet Transplantation Procedure Shows Promise For Patients With Type 1 Diabetes
4. Precise Timing Enabled Pig-to-rat Transplants To Cure Diabetes
5. Diabetes hits 275 Australians each day as pandemic spreads
6. Diabetes research takes wing thanks to long-lived fruit fly
7. Diabetes slows nerve recovery after heart transplant
8. NYU researchers simulate molecular biological clock
9. Vital step in cellular migration described by UCSD medical researchers
10. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
11. UCSD researchers maintain stem cells without contaminated animal feeder layers

Post Your Comments:
(Date:11/23/2009)... release is available in German . , Of all ...cumulate in the atmosphere where it contributes to...ceans and terrestrial ecosystems such as forests, ...service" of aquatic and terrestrial ecosystems is ...ways of reducing climate change. However, new gree...
(Date:11/22/2009)...sus of Marine Life scientists have inventoried an ...of deep sea species that have never known sunlight...gid black world down to 5,000 meters (~3 miles) be...cameras, sonar and other vanguard technologies, an...s now number 17,650, a diverse collection of speci...
(Date:11/22/2009)...bridge, MA November 23, 2009 Agios Pharmaceutica...ished, for the first time, that the mutated IDH1 g...cancer-causing gene, or oncogene. This breakthroug...oduces a metabolite, 2-hydroxyglutarate (2HG), whi...rogression of gliomas, the most common type of bra...
Breaking Biology News(10 mins):Intensive land management leaves Europe without carbon sinks 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 3Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 4Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 5Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 6Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 7Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 8Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 9Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 3Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 4Gain Entry to the Closed 2009 Chicago Marathon by Joining Susan G Komens Marathon for the Cure 28R 29 48393 1Gain Entry to the Closed 2009 Chicago Marathon by Joining Susan G Komens Marathon for the Cure 28R 29 48393 2New Analysis Shows Efficacy of SIMPONI 28TM 29 28golimumab 29 in Anti TNF Experienced Rheumatoid Arthritis Patients 4579 1New Analysis Shows Efficacy of SIMPONI 28TM 29 28golimumab 29 in Anti TNF Experienced Rheumatoid Arthritis Patients 4579 2New Analysis Shows Efficacy of SIMPONI 28TM 29 28golimumab 29 in Anti TNF Experienced Rheumatoid Arthritis Patients 4579 3New Analysis Shows Efficacy of SIMPONI 28TM 29 28golimumab 29 in Anti TNF Experienced Rheumatoid Arthritis Patients 4579 4New Analysis Shows Efficacy of SIMPONI 28TM 29 28golimumab 29 in Anti TNF Experienced Rheumatoid Arthritis Patients 4579 5New Analysis Shows Efficacy of SIMPONI 28TM 29 28golimumab 29 in Anti TNF Experienced Rheumatoid Arthritis Patients 4579 6New Analysis Shows Efficacy of SIMPONI 28TM 29 28golimumab 29 in Anti TNF Experienced Rheumatoid Arthritis Patients 4579 7New Analysis Shows Efficacy of SIMPONI 28TM 29 28golimumab 29 in Anti TNF Experienced Rheumatoid Arthritis Patients 4579 8New Analysis Shows Efficacy of SIMPONI 28TM 29 28golimumab 29 in Anti TNF Experienced Rheumatoid Arthritis Patients 4579 9New Analysis Shows Efficacy of SIMPONI 28TM 29 28golimumab 29 in Anti TNF Experienced Rheumatoid Arthritis Patients 4579 10Landmark Study Published in New England Journal of Medicine 48389 1Landmark Study Published in New England Journal of Medicine 48389 2Landmark Study Published in New England Journal of Medicine 48389 3
...DA, Md. (July 1, 2008) Recipe to recover more quic...wash down with five or six cups of strong coffee. ...ng exercise, is replenished more rapidly when athl...ng exhaustive exercise, new research from the onli...shows. Athletes who ingested caffeine with carbohy...
...ogy of penguins makes these iconic swimming and di... susceptible to environmental changes. Pronounced ...shing, mining, and oil and gas development at lowe...according to P. Dee Boersma, of the University of ...ue of BioScience, Boersma provides a first-perso...
... July 1, 2008 The current standard practice of gi...event brain damage caused by oxygen deprivation ma... UT Southwestern Medical Center have found. , Bra...ypoxic-ischemic brain injury, is one of the most c...amage among infants and children. This can happen ...
Other Biology News:Post-exercise caffeine helps muscles refuel 2Post-exercise caffeine helps muscles refuel 3Post-exercise caffeine helps muscles refuel 4Resuscitation technique after brain injury may do more harm than good 2
(Date:11/23/2009)...Newswire/--ImmuneDesignC or p.(IDC)announcedtodayt...an.Dr.Carterhasasuccessfultrackrec or dinbiotechno...tiveOfficeratZymoGenetics,inSeattle,WAandChiefScie..., (Photo: http://www.newscom.com/cgi-bin/prnh/2...andChiefExecutiveOfficercommented,"Iamdelightedtow...
(Date:11/23/2009)...f.,Nov.23/PRNewswire/--Frost&Sullivan,theGrowt...emonstratingleadershipandinnovationThursday,Novemb...dsBanquetheldinSanAntonio,Texas. ,, (Logo: http...,, TheHealthcareInnovationAwardsaregiventocompa...eryandmanagementofhealthcare.Suchcompanieshaveshow...
(Date:11/23/2009)...PRNewswire-FirstCall/--CornerstoneTherapeuticsInc....usedonacquiring,developingandcommercializingsignif...arkets,todayannouncedthatCraigA.Collard,Presidenta...overviewatthe21stAnnualPiperJaffrayHealthCareConfe...orkPalaceHotelinNewYorkCity. ,, Aliveaudioandar...
(Date:11/20/2009)...n countries have an opportunity to take the lead i...m the University of Valencia (UV), working togethe...oductive fabric of the Spanish biotechnology indus...nt sectors have more clout than those in English-s... food and plants has been overlooked by the leadin...
Breaking Biology Technology:Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Spanish biotechnology should focus on food and plant sectors to be more competitive 2
...ved for Marketing in the United States, Trade Name... TOKYO and INDIANAPOLIS, Jan. 4 Daiichi Sankyo,C...any (NYSE: LLY ) today,announced that on Wednesda...ation (NDA) for prasugrel to the U.S. Food and Dru...latelet agent, initially in development,for the tr...
... Calif., Jan. 4 Thermage, Inc.,(Nasdaq: THRM ), ...aesthetic,industry, announced today that it will p... Conference at The Palace Hotel in New York City. ..., January 11, 2008 at 11:00,a.m. Eastern Time. Ste...cutive Officer, will review the Company,s business...
...ORK (Oct. 31, 2007) -- In the face of terrorism an...trauma systems that improve survival for criticall...Yet many fundamental assumptions underlying these ...e to send the sickest patients to the hospital fir...tific scrutiny. Now, for the first time, researche...
Other Biology Technology:Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration 2Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration 3Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration 4Triage study challenges notions of emergency medical response to disaster 2Triage study challenges notions of emergency medical response to disaster 3Triage study challenges notions of emergency medical response to disaster 4
...power supply are used for submerged horizontal gel... This Model 192 cell includes a buffer tank, a 25 ...uler, and a gel caster. The PowerPac basic power s...0-300 V, 4-400 mA, and 75 W. Power cord and instru...
...ages over traditional electrophoresis for DNA quan...nalysis, and size polymorphisms analysis. The eas...eal for basic research, method development, and qu...ry electrophoresis (CE) systems offer the ruggedne...
...ance of error. Thats the safeguard built into the ...ve experience in laboratory automation and leaders...EQ 8000 is a fully automated genetic analysis syst...array with a patented linear polyacrylamide (LPA) ...
Imaging Screen-K (Kodak), 35 x 43 cm from Bio-Rad
Biology Products: